Arcturus Therapeutics Holdings Inc. ARCT
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2013-05-22
Arcturus Therapeutics Holdings Inc. statistics & valuation
Market cap$195.6M
P / S2.4×
P / B0.9×
Net margin-80.2%
Return on equity-30.7%
FCF margin-90.8%
Return on capital-32.5%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating margin | -93.0% | -62.8% | -46.9% | 5.9% | -1641.3% | -749.8% | -122.7% | -138.5% |
| Net margin | -80.2% | -53.1% | -17.8% | 4.5% | -1648.0% | -756.3% | -125.0% | -138.3% |
| FCF margin | -90.8% | -39.7% | -12.6% | 11.8% | -1120.2% | -467.6% | -34.9% | -141.2% |
| Return on assets | -24.3% | -23.5% | -6.9% | 2.1% | -51.8% | -15.1% | -31.6% | -49.3% |
| Return on equity | -30.7% | -33.6% | -10.7% | 3.5% | -89.2% | -18.2% | -100.8% | -159.7% |
| Debt / equity | — | — | — | — | 0.18× | 0.04× | 0.60× | 0.73× |
| Current ratio | 6.64 | 4.67 | 4.72 | 3.18 | 3.81 | 9.45 | 3.48 | 3.33 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.